Insider Trading History of Gershell Leland

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Gershell Leland since 2013. The trader's CIK number is 1563615. At the time of the last reporting, Gershell Leland was the CFO and Treasurer of Capricor Therapeutics, Inc.. (stock ticker symbol CAPR). Also see all insider trading activities at Capricor Therapeutics, Inc..

Note that in the past GERSHELL LELAND also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Tonix Pharmaceuticals Holding Corp. (TNXP) by Gershell Leland

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 TNXP 6,400 $39,080 0 $0 0 $0
2013 TNXP 4,330 $3,946 0 $0 0 $0

Yearly summary of insider trading at Capricor Therapeutics, Inc. (CAPR) by Gershell Leland

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 CAPR 2,100 $5,040 0 $0 0 $0


Insider trading activities at 2 companies by Gershell Leland:

1. Tonix Pharmaceuticals Holding Corp. (TNXP)

2. Capricor Therapeutics, Inc. (CAPR)

Table 1. Insider trading of Tonix Pharmaceuticals Holding Corp. (TNXP) by Gershell Leland

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-09-28 TNXP Buy 400 5.83 2,330
2015-07-17 TNXP Buy 1,000 7.50 7,500
2015-02-09 TNXP Buy 5,000 5.85 29,250
2013-09-06 TNXP Buy 500 3.40 1,700
2013-08-14 TNXP Buy 3,530 .00 0
2013-05-23 TNXP Buy 50 7.49 374
2013-05-24 TNXP Buy 150 7.49 1,123
2013-05-21 TNXP Buy 100 7.49 749

Table 2. Insider trading of Capricor Therapeutics, Inc. (CAPR) by Gershell Leland

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-16 CAPR Buy 2,100 2.40 5,040

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gershell Leland (CFO and Treasurer of Capricor Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.